Glyphosate: Hepatotoxicity,Nephrotoxicity, Hemotoxicity,Carcinogenicity, and Clinical Cases of Endocrine, Reproductive, Cardiovascular,and Pulmonary System Intoxication
Glyphosate (GLP) is an active agent of GLP-based herbicides(GBHs),i.e., broad-spectrum and postemergent weedkillers, commercializedby Monsanto as, e.g., Roundup and RangerPro formulants. The GBH cropspraying, dedicated to genetically engineered GLP-resistant crops,has revolutionized modern agriculture by increasing the productionyield. However, abusively administered GBHs’ ingredients, e.g.,GLP, polyoxyethyleneamine, and heavy metals, have polluted environmentaland industrial areas far beyond farmlands, causing global contaminationand life-threatening risk, which has led to the recent local bansof GBH use. Moreover, preclinical and clinical reports have demonstratedharmful impacts of GLP and other GBH ingredients on the gut microbiome,gastrointestinal tract, liver, kidney, and endocrine, as well as reproductive,and cardiopulmonary systems, whereas carcinogenicity of these herbicidesremains controversial. Occupational exposure to GBH dysregulates thehypothalamic–pituitary–adrenal axis, responsible forsteroidogenesis and endocrinal secretion, thus affecting hormonalhomeostasis, functions of reproductive organs, and fertility. On theother hand, acute intoxication with GBH, characterized by dehydration,oliguria, paralytic ileus, as well as hypovolemic and cardiogenicshock, pulmonary edema, hyperkalemia, and metabolic acidosis, mayoccur fatally. As no antidote has been developed for GBH poisoningso far, the detoxification is mainly symptomatic and supportive andrequires intensive care based on gastric lavage, extracorporeal bloodfiltering, and intravenous lipid emulsion infusion. The current reviewcomprehensively discusses the molecular and physiological basics ofthe GLP- and/or GBH-induced diseases of the endocrine and reproductivesystems, and cardiopulmonary-, nephro-, and hepatotoxicities, presentedin recent preclinical studies and case reports on the accidental orintentional ingestions with the most popular GBHs. Finally, they brieflydescribe modern and future healthcare methods and tools for GLP detection,determination, and detoxification. Future electronically powered,decision-making, and user-friendly devices targeting major GLP/GBH’smodes of actions, i.e., dysbiosis and the inhibition of AChE, shallenable self-handled or point-of-care professional-assisted evaluationof the harm followed with rapid capturing GBH xenobiotics in the bodyand precise determining the GBH pathology-associated biomarkers levels.
Read more